Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy and Bevacizumab in Patients With Recurrent, Persistent or Metastatic Cervical Cancer (CAESURA)
Clinical trial NCT03912402 · UNKNOWN
Trial details
- NCT number
- NCT03912402
- Sponsor
- Biocad
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-25
- Primary completion
- 2020-07-07
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.